Boston Private Bank & Trust’s AstraZeneca AZN Stock Holding History

Boston Private Bank & Trust’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	$24K	Hold	355	–	–	﹤0.01%	697
2014 Q4	$25K	Buy	355 +125	+54%	+$8.95K	﹤0.01%	715
2014 Q3	$16K	Hold	230	–	–	﹤0.01%	803
2014 Q2	$17K	Buy	+230	New	+$16.6K	﹤0.01%	760
2014 Q1	–	Sell	-200	Closed	-$12K	–	1019
2013 Q4	$12K	Hold	200	–	–	﹤0.01%	818
2013 Q3	$10K	Buy	+200	New	+$10K	﹤0.01%	804

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

MAA

Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

SCCM

Schafer Cullen Capital Management New York $491M AUM 41.48% 1-Year Est. Return

BIM

BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Boston Private Bank & Trust's AZN Position: Q1 2015 in Review

Boston Private Bank & Trust held its AstraZeneca (AZN) position steady in Q1 2015 at 355 shares worth $24K. The position accounts for ﹤0.01% of the portfolio, ranked #697.

Boston Private Bank & Trust first reported a position in AZN in Q3 2013 and has held it in 6 quarters since. The position peaked at $25K in Q4 2014. 386 funds tracked by Wall St. Rank hold AZN as of Q1 2015.

Boston Private Bank & Trust held 355 shares of AstraZeneca worth $24K as of Q1 2015.
Boston Private Bank & Trust left its AstraZeneca share count unchanged in Q1 2015.
AstraZeneca made up ﹤0.01% of Boston Private Bank & Trust's portfolio in Q1 2015, its #697 holding.
Boston Private Bank & Trust first reported a position in AstraZeneca in Q3 2013 and has held it in 6 quarters since.
Boston Private Bank & Trust's AstraZeneca position peaked at $25K in Q4 2014.
386 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2015.

Based on Boston Private Bank & Trust's 13F filing for Q1 2015, filed 9 Apr 2015.